Antitumor activity of alantolactone in lung cancer cell lines NCI‐H1299 and Anip973

Nogo-B receptor promotes epithelial–mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway

(2018) Donghua Wu et al.   CANCER LETTERS

EGFR and Ras regulate DDX59 during lung cancer development

(2018) Lin Yang et al.   GENE

Influenza A virus induces autophagosomal targeting of ribosomal proteins

(2018) Andrea C Becker et al.   MOLECULAR & CELLULAR PROTEOMICS

MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology

(2018) Guogui Sun et al.   Cell Death & Disease

The effect and mechanism of miR-210 in down-regulating the autophagy of lung cancer cells

(2018) Sheng Ju et al.   PATHOLOGY RESEARCH AND PRACTICE

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

(2017) Eugenio Paci et al.   THORAX

Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress

(2017) Amara Maryam et al.   Scientific Reports

Obtaining alantolactone and isoalantolactone from Inula racemose Hook.f. by optimized supercritical fluid extraction

(2016) Xiao-Feng Chi et al.   INDUSTRIAL CROPS AND PRODUCTS

Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways

(2016) Ling Ning et al.   INTEGRATIVE CANCER THERAPIES

Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

(2016) Yahui Ding et al.   Journal of Hematology & Oncology

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting

(2016) Danielle Rodin et al.   Journal of Thoracic Oncology

EGFR as a Pharmacological Target in EGFR -Mutant Non-Small-Cell Lung Cancer: Where Do We Stand Now?

(2016) E-->-E -->Ke et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells

(2015) Jaemoo Chun et al.   CANCER LETTERS

Pipoxolan inhibits CL1–5 lung cancer cells migration and invasion through inhibition of MMP-9 and MMP-2

(2015) Min-Min Lee et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Experience with erlotinib in the treatment of non-small cell lung cancer

(2015) Lorenza Landi et al.   Therapeutic Advances in Respiratory Disease

Mig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathways

(2014) Yun-wei Ou et al.   ACTA PHARMACOLOGICA SINICA

Baicalin Suppresses Migration, Invasion and Metastasis of Breast Cancer via p38MAPK Signaling Pathway

(2013) Xiu- Wang et al.   Anti-Cancer Agents in Medicinal Chemistry

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion

(2013) Wei Wei et al.   APOPTOSIS

Emerging roles of lipids in BCL-2 family-regulated apoptosis

(2013) Tejia Zhang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression

(2013) Chunhui Yang et al.   IUBMB LIFE

Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression

(2013) Xu-Guang Mi et al.   TOXICOLOGY LETTERS

Alantolactone induces activation of apoptosis in human hepatoma cells

(2012) Jia-Chuan Lei et al.   FOOD AND CHEMICAL TOXICOLOGY

Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells

(2012) Jaemoo Chun et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Molecular Mechanism of Silymarin-Induced Apoptosis in a Highly Metastatic Lung Cancer Cell Line Anip973

(2011) Wenhai Li et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Apoptosis in cancer: from pathogenesis to treatment

(2011) Rebecca SY Wong   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells

(2010) Harald J. Maier et al.   CANCER LETTERS

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL